BRPI0605967A - composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêutica - Google Patents
composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêuticaInfo
- Publication number
- BRPI0605967A BRPI0605967A BRPI0605967-8A BRPI0605967A BRPI0605967A BR PI0605967 A BRPI0605967 A BR PI0605967A BR PI0605967 A BRPI0605967 A BR PI0605967A BR PI0605967 A BRPI0605967 A BR PI0605967A
- Authority
- BR
- Brazil
- Prior art keywords
- release
- controlled release
- soluble
- pharmaceutical form
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0605967-8A BRPI0605967A (pt) | 2006-12-20 | 2006-12-20 | composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêutica |
PCT/BR2007/000331 WO2008074108A2 (en) | 2006-12-20 | 2007-12-05 | Controlled release pharmaceutical composition of anti-hyperglycemic agent and its preparation |
CL200703675A CL2007003675A1 (es) | 2006-12-20 | 2007-12-18 | Composicion farmaceutica de liberacion controlada, que comprende un nucleo bioadherente, conteniendo un agente antiglucemiante y como agente regulador de liberacion controlada el acido poliacrilico polimerizado sin benceno o sus derivados; procedimie |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0605967-8A BRPI0605967A (pt) | 2006-12-20 | 2006-12-20 | composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêutica |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0605967A true BRPI0605967A (pt) | 2008-08-12 |
Family
ID=39536766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0605967-8A BRPI0605967A (pt) | 2006-12-20 | 2006-12-20 | composição farmacêutica de liberação controlada, forma farmacêutica de liberação controlada e processo para obtenção de forma farmacêutica |
Country Status (3)
Country | Link |
---|---|
BR (1) | BRPI0605967A (pt) |
CL (1) | CL2007003675A1 (pt) |
WO (1) | WO2008074108A2 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011111068A2 (en) | 2010-03-09 | 2011-09-15 | Council Of Scientific And Industrial Research | Gastroretentive, extended release composition of therapeutic agent |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN192180B (pt) * | 2001-09-28 | 2004-03-06 | Ranbaxy Lab | |
US20030187074A1 (en) * | 2002-03-04 | 2003-10-02 | Javed Hussain | Oral compositions for treatment of diabetes |
WO2005092293A1 (en) * | 2004-03-22 | 2005-10-06 | Ranbaxy Laboratories Limited | Formulations of metformin |
-
2006
- 2006-12-20 BR BRPI0605967-8A patent/BRPI0605967A/pt not_active IP Right Cessation
-
2007
- 2007-12-05 WO PCT/BR2007/000331 patent/WO2008074108A2/en active Application Filing
- 2007-12-18 CL CL200703675A patent/CL2007003675A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2008074108A3 (en) | 2008-12-11 |
CL2007003675A1 (es) | 2008-06-27 |
WO2008074108A2 (en) | 2008-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2962574T3 (es) | Administración de agentes biológicamente activos utilizando disolventes volátiles hidrófobos | |
BRPI0620063B8 (pt) | composição farmacêutica de liberação sustentada na forma de micropartículas, uso, e kit de administração | |
ES2557988T3 (es) | Método para tratar enfermedades de próstata basado en el suministro local de principios activos | |
BR0312268A (pt) | Dispositivos transdermais para liberação de droga que têm microprotrusões revestidas | |
AR067495A1 (es) | Composiciones farmaceuticas y procedimientode tratamientos de trastornos de ojo seco | |
BR0213948A (pt) | Forma de dosagem de liberação controlada dual | |
MXPA04003742A (es) | Farmaco conteniendo 3-(3-dimetilamino-1-etil-2-metil-propil)fenol con liberacion lenta de la sustancia activa. | |
MX2009004874A (es) | Formulaciones farmaceuticas estratificadas que comprenden una capa intermediaria que se disuelve rapidamente. | |
ECSP099387A (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis | |
CL2010000816A1 (es) | Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06) | |
BRPI0513300A (pt) | forma farmacêutica oral, protegida frente ao abuso, contendo (1r, 2r)-3-(3-dimetilamino-1-etil-2-propil)-fenol | |
GT200900056A (es) | Benzoxazoles y oxazolopiridinas utiles como inhibidores de la quinasa janus | |
BR9808888A (pt) | Formas de dosagem e método de melhorar disfunção erétil masculina | |
WO2006048747A8 (en) | Topical pharmaceutical compositions containing an antiacne compound and antibiotic compound | |
UY28034A1 (es) | Antagonistas de cgrp elegidos, procedimiento para su preparacion asi como su empleo como medicamentos | |
BRPI0518266A2 (pt) | medicamento oral de libertaÇço modificada de pelo menos um princÍpio ativo sob a forma multimicrocapsular | |
BRPI0509194A (pt) | formulação e método de comprimido revestido | |
ATE476997T1 (de) | Zusammensetzung und dosierform mit einer festen oder halbfesten matrix | |
CY1108676T1 (el) | Οφθαλμικο εναιωρημα περιλαμβανον ενα οφθαλμικο φαρμακο, μια πολοξαμινη και εναν παραγοντα ρυθμισεως της τονικοτητας τυπου γλυκολης, χρηση της εν λογω συνθεσεως για την παραγωγη ενος φαρμακου για την αγωγη οφθαλμικων διαταραχων | |
AR034517A1 (es) | Formulacion farmaceutica | |
GT200900089A (es) | Composicion farmaceutica en forma de microesferas recubiertas para la liberacion modificada de un relajante muscular y un aine | |
PE20040416A1 (es) | Formulacion de alta dosis de ibandronato | |
PE20150773A1 (es) | Composiciones farmaceuticas para la liberacion sostenida de fenilefrina | |
BR0114272A (pt) | Formulação farmacêutica de liberação prolongada independente da força iÈnica | |
BRPI0608917A2 (pt) | Composição de liberação controlada de antibiótico, e, método para o tratamento de infecção bacteriana |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03A | Publication of an application: publication of a patent application or of a certificate of addition of invention | ||
B25D | Requested change of name of applicant approved |
Owner name: MEDLEY INDUSTRIA FARMACEUTICA LTDA (BR/SP) Free format text: ALTERADO DE: MEDLEY S.A. INDUSTRIA FARMACEUTICA |
|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B25C | Requirement related to requested transfer of rights |
Owner name: MEDLEY INDUSTRIA FARMACEUTICA LTDA (BR/SP) Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 860140200022 DE 28/11/2014, E NECESSARIO APRESENTAR UMA GUIA RELATIVA A ALTERACAO DE NOME OCORRIDA, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA. |
|
B25A | Requested transfer of rights approved |
Owner name: MEDLEY COMERCIAL E LOGISTICA LTDA. (BR/SP) |
|
B25D | Requested change of name of applicant approved |
Owner name: MEDLEY FARMACEUTICA LTDA (BR/SP) |
|
B08H | Application fees: decision cancelled | ||
B08F | Application fees: dismissal - article 86 of industrial property law | ||
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2418 DE 09/05/2017. |